Home › Anaplastic Large-Cell Lymphoma › Arizona
Anaplastic Large-Cell Lymphoma clinical trials in Arizona
3 studies for Anaplastic Large-Cell Lymphoma are looking for participants at sites in Arizona.
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Mayo Clinic Hospital in Arizona, Phoenix
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06724237Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06508463A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT03017820From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.